Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Peterse

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
British Journal of Cancer|December 22, 1999
Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic typeC B Vos, N T ter Haar, C Rosenberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Feasibility study of FEC-chemotherapy with dose-intensive epirubicin as initial treatment in high-risk breast cancerE van der Wall, D J Richel, Y H Kusumanto, et al.
British Journal of Cancer|May 1, 1996
Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patientsE van der Wall, E J Rutgers, M J Holtkamp, et al.
Diagnostic Cytopathology|November 14, 1997
Which cytological criteria are the most discriminative to distinguish carcinoma, lymphoma, and soft-tissue sarcoma? A probabilistic approachF B Thunnissen, A H Kroese, A W Ambergen, et al.
British Journal of Cancer|February 5, 2004
Diagnostic accuracy for different strategies of image-guided breast intervention in cases of nonpalpable breast lesionsR M Pijnappel, M van den Donk, R Holland, et al.
Lancet (London, England)|February 22, 2000
Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy GroupJ P Julien, N Bijker, I S Fentiman, et al.
Breast Cancer Research and Treatment|September 23, 2008
The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort studyK E Pengel, C E Loo, H J Teertstra, et al.
Annals of Surgical Oncology|April 21, 2001
Frozen section investigation of the sentinel node in malignant melanoma and breast cancerP J Tanis, R P Boom, H S Koops, et al.
British Journal of Cancer|September 29, 2005
No common denominator for breast cancer lymph node metastasisB Weigelt, L F A Wessels, A J Bosma, et al.
Breast Cancer Research and Treatment|April 14, 2007
Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populationsH M Verkooijen, V C M Koot, G Fioretta, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
British Journal of Cancer|December 22, 1999
Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic typeC B Vos, N T ter Haar, C Rosenberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Feasibility study of FEC-chemotherapy with dose-intensive epirubicin as initial treatment in high-risk breast cancerE van der Wall, D J Richel, Y H Kusumanto, et al.
British Journal of Cancer|May 1, 1996
Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patientsE van der Wall, E J Rutgers, M J Holtkamp, et al.
Diagnostic Cytopathology|November 14, 1997
Which cytological criteria are the most discriminative to distinguish carcinoma, lymphoma, and soft-tissue sarcoma? A probabilistic approachF B Thunnissen, A H Kroese, A W Ambergen, et al.
British Journal of Cancer|February 5, 2004
Diagnostic accuracy for different strategies of image-guided breast intervention in cases of nonpalpable breast lesionsR M Pijnappel, M van den Donk, R Holland, et al.
Lancet (London, England)|February 22, 2000
Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy GroupJ P Julien, N Bijker, I S Fentiman, et al.
Breast Cancer Research and Treatment|September 23, 2008
The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort studyK E Pengel, C E Loo, H J Teertstra, et al.
Annals of Surgical Oncology|April 21, 2001
Frozen section investigation of the sentinel node in malignant melanoma and breast cancerP J Tanis, R P Boom, H S Koops, et al.
British Journal of Cancer|September 29, 2005
No common denominator for breast cancer lymph node metastasisB Weigelt, L F A Wessels, A J Bosma, et al.
Breast Cancer Research and Treatment|April 14, 2007
Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populationsH M Verkooijen, V C M Koot, G Fioretta, et al.
Pageof 13